Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides or immunogenic fragments derived from SEQ ID NO: 35, that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) are provided. The amino acid sequences of the peptide of interest may be optionally modified with the substitution, deletion, insertion, or addition of one, two, or several amino acids sequences. Pharmaceutical compositions and methods of treating cancer that include such peptides are also provided.於此敘述抗癌胜肽疫苗。特別是，提供來自序列辨識號：35之經分離的抗原決定位胜肽或免疫活性片段，人類白血球組織抗原結合且誘發細胞毒殺性T淋巴球。感興趣之胜肽的胺基酸序列可視需要而定，以一、二或數個胺基酸序列的取代、刪除、插入或加入來修飾。也提供包括此種胜肽之治療癌症的藥學組合物與方法。
